![]() |
市場調查報告書
商品編碼
2096496
尿液排放袋市場-全球市場預測(2026-2032年)Urinary Drainage Bags Market - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,尿液排放袋市場規模將達到 30.2 億美元,複合年成長率為 7.18%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 18.5億美元 |
| 預計年份:2026年 | 19.8億美元 |
| 預測年份 2032 | 30.2億美元 |
| 複合年成長率 (%) | 7.18% |
尿袋是急診、長期照護、居家醫療、復健和術後恢復中必不可少的醫療設備,用於收集和管理需要導尿或膀胱排尿管理的患者的尿液。其需求與臨床驗證的因素密切相關,例如人口老化、尿失禁盛行率上升、脊髓損傷、神經源性膀胱、泌尿系統手術、運動功能受限以及需要精確監測尿量等。既定的臨床指引指出,尿道導管和排尿管理系統在手術全期護理、重症監護和某些閉尿症病例中至關重要,而感染預防仍然是產品使用和採購決策的核心考量。
尿袋產業正經歷重大變革,從基本的尿液收集產品轉向以患者為中心的一體化引流解決方案。感染預防是重塑採購和產品設計的關鍵因素之一,因為導尿管相關尿道感染( UTI)已被公共衛生機構廣泛認定為最常見的醫療相關感染疾病之一。這促使人們越來越重視密封引流系統、無菌操作、安全的導尿管連接、降低污染風險的引流口以及防止尿液從尿袋回流至膀胱的設計。
人工智慧正開始影響尿袋生態系統,其主要影響途徑是透過相關的醫療和製造功能,而非對標準尿袋產品進行廣泛的直接自動化。在臨床環境中,人工智慧驅動的病患監測和電子健康記錄分析,結合尿量趨勢、生命徵象、實驗室檢查結果、用藥史、體液平衡和導尿管留置時間等信息,有助於早期發現泌尿系統併發症。這在加護病房、術後恢復期和高風險環境中尤其重要,因為尿量是這些情況下的關鍵臨床指標。
アジア太平洋地域では、医療へのアクセスが拡大し、手術件数が増加しているほか、大規模高齢化人口により閉尿症、尿失禁、および慢性疾患の管理負担が増大していることから、尿排出バッグへの需要が高まっています。日本、中国、インド、韓国、オーストラリアの各市場では、高度な高齢者医療や病院内の感染管理プログラムから、公的,民間医療システムにおけるアクセス拡大に至るまで、それぞれ異なる需要パターンが見られます。また、この地域は、確立された醫療設備製造能力に加え、品質、無菌性、患者の安全性に関する規制の整合性が高まっていることも追い風となっています。
北約成員國(其中許多與醫療已開發經濟體重疊)優先考慮具有韌性的醫療供應鏈、標準化的品質、緊急準備以及可靠地獲取必要的醫院耗材,包括用於急診和急救的尿液引流袋。七國集團(G7)國家的特點是醫療體系成熟、人口老化、擁有完善的感染控制計劃,並且對臨床證據、供應連續性、以患者為中心的設計以及上市後品質監測抱有很高的期望。金磚國家擁有龐大的患者群體,醫療服務覆蓋範圍不斷擴大,國內生產能力增強,慢性病負擔日益加重,因此對經濟高效且性能卓越的尿液引流解決方案有著廣泛的需求。
在中國,尿袋市場規模龐大且持續發展,其成長動力主要來自醫院擴張、人口老化、外科手術量增加、國內醫療設備生產。在美國,醫院、療養院、家庭醫療保健和復健機構的需求強勁,臨床重點在於減少導尿管相關尿道感染,並改善導尿管使用必要性的記錄。在日本,由於其作為全球老化程度最高的國家之一,以及居家醫療和老年護理的高標準,預計尿袋需求將保持穩定。在印度,外科手術的普及、私立醫療保健的發展以及泌尿系統和長期護理服務可近性的提高,都支撐了尿袋的需求,而價格和供應仍然是重要的採購因素。
產業領導者應優先考慮經臨床驗證的感染預防功能。這些功能包括安全密封的引流裝置、防回流功能、可靠的引流口、安全的檢體採集口、防纏繞導管,以及能夠在已批准的臨床方案下安全長期使用的材料。產品開發應著重於提升病患的舒適度和看護者的工作效率。特別是腿部引流袋、夜間引流袋、床邊引流袋和居家照護系統,應具備隱蔽性佳、固定牢固、易於引流、洩漏風險低以及容量清晰可見等特性。
本執行摘要基於二手資料研究和系統性的行業分析編寫而成,參考了包括公共衛生機構指南、醫療設備法規結構、臨床實踐指南、關於檢驗相關尿道感染預防的同行評審文獻、人口資訊來源統計數據以及已記錄的醫療保健基礎設施發展趨勢等權威來源。評估從臨床應用、護理環境、材料和設計考慮、監管要求、感染預防措施以及採購因素等方面對尿液引流袋進行了評論。
尿袋在現代醫療保健中仍然至關重要,它支持尿液收集、臨床監測、術後復健、長期導尿管護理以及居家泌尿道管理。由於感染預防、人口老化、居家醫療的擴展、更嚴格的監管要求以及對以患者為中心的產品設計的需求,該行業正在經歷變革。雖然人工智慧 (AI) 目前還不是標準尿袋的主要功能,但它在製造品質、庫存管理、臨床監測、採購計劃和數位化護理工作流程中的重要性日益凸顯。
The Urinary Drainage Bags Market is projected to grow by USD 3.02 billion at a CAGR of 7.18% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 1.85 billion |
| Estimated Year [2026] | USD 1.98 billion |
| Forecast Year [2032] | USD 3.02 billion |
| CAGR (%) | 7.18% |
Urinary drainage bags are essential medical devices used across acute care, long-term care, home healthcare, rehabilitation, and post-operative recovery to collect and manage urine from patients requiring catheterization or controlled bladder drainage. Demand is closely linked to clinically verified factors such as aging populations, higher prevalence of urinary incontinence, spinal cord injuries, neurogenic bladder, urological surgeries, mobility limitations, and hospital care pathways that require accurate urine output monitoring. According to established clinical guidance, urinary catheter and drainage systems are critical in perioperative care, intensive care, and selected cases of urinary retention, while infection prevention remains central to product use and procurement decisions.
The urinary drainage bags landscape is shaped by the need to reduce catheter-associated urinary tract infections, improve patient mobility, strengthen caregiver safety, and support home-based care. Hospitals and care providers increasingly prioritize closed urinary drainage systems, anti-reflux valves, secure tubing, needle-free sampling ports, comfortable leg bags, high-capacity night drainage bags, and materials designed for durability and skin compatibility. As healthcare systems shift toward value-based outcomes and infection control compliance, urinary drainage bag selection is increasingly evaluated through clinical performance, usability, regulatory quality, and lifecycle cost rather than unit price alone.
The urinary drainage bags industry is undergoing a significant transition from basic urine collection products toward integrated, patient-centered drainage solutions. Infection prevention is one of the most important forces reshaping procurement and product design, as catheter-associated urinary tract infections are widely recognized by public health agencies as among the most common healthcare-associated infections. This has increased emphasis on closed drainage systems, sterile handling, secure catheter connections, drainage ports that reduce contamination risk, and designs that prevent reflux from the bag to the bladder.
A second major shift is the expansion of care beyond hospitals. Home healthcare, outpatient surgery, and long-term care facilities require urinary drainage bags that are easier to use, discreet, comfortable, and compatible with patient mobility. Leg bags, bedside bags, urine meter bags, and drainage sets are increasingly assessed for wearability, odor control, secure straps, emptying convenience, leakage resistance, and caregiver-friendly handling. Sustainability is also entering purchasing conversations, particularly in Europe and other regions with strong healthcare waste reduction agendas; however, product changes must continue to meet sterility, biocompatibility, performance, and regulatory requirements. Together, these shifts are moving the sector toward safer, more ergonomic, and more accountable urinary drainage management.
Artificial intelligence is beginning to influence the urinary drainage bags ecosystem primarily through adjacent healthcare and manufacturing functions rather than through widespread direct automation of standard bag products. In clinical settings, AI-enabled patient monitoring and electronic health record analytics can support early identification of urinary complications by combining urine output trends with vital signs, laboratory values, medication history, fluid balance, and catheter duration. This is especially relevant in intensive care, post-operative recovery, and high-acuity environments where urine output is a key clinical indicator.
In manufacturing and quality operations, AI-based visual inspection, predictive maintenance, and process analytics can improve consistency in tubing, seals, ports, valves, connectors, and sterile barrier packaging. Supply chain analytics can also help healthcare providers and distributors anticipate demand variability driven by elective procedures, emergency care volumes, seasonal illness patterns, and long-term care utilization. The cumulative impact of AI is expected to be strongest where digital documentation, device traceability, infection surveillance, and procurement optimization intersect. For industry participants, the practical opportunity lies in using AI to strengthen quality assurance, reduce stockouts, support compliance documentation, and generate evidence around product performance without compromising patient privacy or clinical safety.
Asia-Pacific is experiencing rising need for urinary drainage bags as healthcare access expands, surgical volumes grow, and large aging populations increase the burden of urinary retention, incontinence, and chronic disease management. Japan, China, India, South Korea, and Australia each present distinct demand patterns, ranging from advanced geriatric care and hospital infection control programs to broader access expansion in public and private healthcare systems. The region also benefits from established medical device manufacturing capabilities and increasing regulatory alignment around quality, sterility, and patient safety.
Europe is shaped by strict medical device regulation, environmental health policy, and a strong focus on patient safety, clinical evidence, traceability, and healthcare-associated infection prevention. Hospitals and long-term care settings increasingly assess urinary drainage bags through quality compliance, usability, material safety, and sustainability considerations. North America remains characterized by strong infection prevention protocols, mature hospital procurement systems, and broad use of urinary drainage bags in acute care, home healthcare, nursing facilities, and rehabilitation settings. Regulatory oversight, clinical guidelines for catheter use, and reimbursement-linked quality measures reinforce demand for reliable closed drainage systems and products that support catheter-associated urinary tract infection reduction.
Latin America is advancing through expanding hospital infrastructure, private healthcare investment, and growing attention to post-surgical care and chronic disease management, although access and procurement consistency vary across countries and care settings. Africa presents a diverse landscape, with needs driven by essential hospital care, maternal and surgical services, long-term catheter management, and efforts to strengthen infection prevention in resource-constrained settings. The Middle East is investing in hospital modernization, specialty care, and medical tourism in several countries, supporting demand for advanced urinary management products in acute, urology, rehabilitation, and post-operative care.
NATO member countries, many of which overlap with advanced healthcare economies, place importance on resilient medical supply chains, standardized quality, emergency preparedness, and reliable access to essential hospital consumables, including urinary drainage bags used in acute and emergency care. G7 countries are defined by mature healthcare systems, aging demographics, formal infection control programs, and higher expectations for clinical evidence, supply continuity, patient-centered design, and post-market quality oversight. BRICS countries combine large patient populations, expanding healthcare access, domestic manufacturing capacity, and rising chronic disease burdens, creating a broad need for both cost-effective and higher-performance urinary drainage solutions.
The European Union is highly influenced by stringent medical device requirements, post-market surveillance expectations, clinical documentation standards, and sustainability policies that affect procurement decisions across urinary drainage bags and related catheter care products. ASEAN healthcare systems are increasing their focus on affordable, reliable urinary drainage bags as hospital networks expand and outpatient and home-based care models gain attention. Countries in the group show varied levels of procurement sophistication, but infection control, product availability, affordability, and ease of use remain common purchasing priorities. GCC markets are influenced by hospital infrastructure investment, strong demand for high-quality medical devices, and the development of advanced specialty care services, making regulatory compliance, premium product performance, and clinical reliability central to adoption.
China has a large and evolving urinary drainage bag environment driven by hospital expansion, aging demographics, higher surgical utilization, and domestic medical device production. The United States shows strong demand across hospitals, skilled nursing facilities, home healthcare, and rehabilitation environments, with clinical emphasis on reducing catheter-associated urinary tract infections and improving documentation of catheter necessity. Japan faces sustained demand from one of the world's oldest populations and strong care standards in hospitals and eldercare. India's need is supported by growing surgical care, expanding private healthcare, and broader access to urology and long-term care services, with affordability and availability remaining important procurement factors.
Germany, the United Kingdom, France, Italy, and Spain are shaped by aging populations, established urology services, and regulatory frameworks that prioritize safety, traceability, and product performance. Germany emphasizes high-quality medical technology and hospital performance, while the United Kingdom places strong emphasis on clinical guidelines, community care pathways, and catheter-associated infection prevention. France is guided by regulated procurement and patient safety priorities, Italy by regional healthcare delivery and long-term care needs, and Spain by public hospital utilization, eldercare, and post-operative urinary management requirements.
Australia emphasizes regulated quality, home healthcare compatibility, and infection prevention, while South Korea combines advanced hospital infrastructure, technology adoption, and growing elderly care needs to support the use of reliable urinary drainage systems. Canada follows a quality- and safety-oriented approach, with procurement shaped by public healthcare systems, aging demographics, and infection prevention standards. Russia presents demand linked to hospital care, urology procedures, and domestic supply considerations, with procurement shaped by healthcare modernization and localization priorities. Brazil and Mexico are influenced by expanding hospital capacity, public-private care delivery, and rising need for post-operative and chronic urinary management, while access and standardization vary by region and care setting.
Industry leaders should prioritize clinically validated infection prevention features, including secure closed drainage, anti-reflux functionality, reliable drainage outlets, safe sampling access, kink-resistant tubing, and materials that support safe extended use within approved clinical protocols. Product development should focus on patient comfort and caregiver efficiency, particularly for leg bags, night drainage bags, bedside drainage bags, and homecare-compatible systems that require discreet wear, secure fixation, easy emptying, low leakage risk, and clear volume visibility.
Manufacturers and suppliers should strengthen regulatory documentation, post-market surveillance, sterilization validation, biocompatibility evidence, and quality management systems to meet increasingly strict requirements across major regions. Building resilient supply chains is also critical, including diversified sourcing for medical-grade polymers, packaging components, valves, tubing, connectors, and sterilization capacity. Commercial teams should align offerings with care setting needs, differentiating between acute care, long-term care, home healthcare, rehabilitation, and urology specialty use. Evidence generation should focus on usability, leakage prevention, infection control support, caregiver handling, and patient satisfaction rather than price-only positioning. Digital initiatives, including inventory analytics and traceability systems, can further improve procurement reliability and clinical accountability.
This executive summary is developed through secondary research and structured industry analysis using verified sources such as public health agency guidance, medical device regulatory frameworks, clinical practice recommendations, peer-reviewed literature on catheter-associated urinary tract infection prevention, demographic health statistics, and documented healthcare infrastructure trends. The assessment evaluates urinary drainage bags across clinical applications, care settings, material and design considerations, regulatory requirements, infection prevention practices, and procurement drivers.
The methodology emphasizes data-backed interpretation without using market sizing, market share, market estimation, or forecasting. Regional, group, and country insights are synthesized from observable healthcare indicators, including aging population trends, hospital infection control priorities, surgical and long-term care utilization, home healthcare expansion, medical device regulation, and supply chain resilience factors. Findings are validated through cross-comparison of authoritative healthcare, regulatory, and clinical sources to ensure relevance, consistency, and practical utility for strategic decision-making.
Urinary drainage bags remain indispensable in modern healthcare, supporting urine collection, clinical monitoring, post-operative recovery, long-term catheter care, and home-based urinary management. The industry is being reshaped by infection prevention, aging populations, expanded home healthcare, stricter regulatory expectations, and the need for patient-friendly product design. While artificial intelligence is not yet a dominant feature of standard drainage bags, it is increasingly relevant to manufacturing quality, inventory management, clinical surveillance, procurement planning, and digital care workflows.
Future competitiveness will depend on the ability to combine safety, usability, compliance, and supply continuity. Organizations that invest in clinically aligned product innovation, robust quality systems, regional regulatory readiness, resilient sourcing, and evidence-based value communication will be better positioned to meet the evolving needs of hospitals, caregivers, and patients across diverse global healthcare settings.